Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma After Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature

Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2012.04.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

Oncology Letters
Cancer ResearchOncology
2012English

Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases
PulmonaryInfectious DiseasesRespiratory Medicine
2011English

Erlotinib in Symptomatic Brain Metastases From a Lung Adenocarcinoma With a Sensitizing EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Leflunomide-Induced Interstitial Lung Disease: A Case Report

Eurasian Journal of Pulmonology
2015English

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2008English

P3.01-104 EGFR-RAD51 Fusion Variant in Lung Adenocarcinoma and Response to Erlotinib: A Case Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non-Small Cell Lung Cancer With Multiple Brain Metastases Treated With Radiosurgery and Erlotinib: A Case Report

Cureus
2017English

Osimertinib-Induced Severe Interstitial Lung Disease: A Case Report

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Gemcitabine Plus Oxaliplatin for the Treatment of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Review of the Literature

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy